Ryman Healthcare Statistics
Total Valuation
Ryman Healthcare has a market cap or net worth of 1.71 billion. The enterprise value is 3.18 billion.
| Market Cap | 1.71B |
| Enterprise Value | 3.18B |
Important Dates
The last earnings date was Wednesday, November 27, 2024.
| Earnings Date | Nov 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +12.70% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 652.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 0.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -56.87 |
| EV / Sales | 7.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 13.04 |
Financial Position
The company has a current ratio of 0.04, with a Debt / Equity ratio of 0.61.
| Current Ratio | 0.04 |
| Quick Ratio | 0.03 |
| Debt / Equity | 0.61 |
| Debt / EBITDA | 2,576.30 |
| Debt / FCF | 6.86 |
| Interest Coverage | -0.28 |
Financial Efficiency
Return on equity (ROE) is -1.92% and return on invested capital (ROIC) is -0.27%.
| Return on Equity (ROE) | -1.92% |
| Return on Assets (ROA) | -0.15% |
| Return on Capital (ROIC) | -0.27% |
| Revenue Per Employee | 59,538 |
| Profits Per Employee | -7,268 |
| Employee Count | 7,700 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 137.56 |
Taxes
| Income Tax | -90.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.26% in the last 52 weeks. The beta is 0.82, so Ryman Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -23.26% |
| 50-Day Moving Average | 13.92 |
| 200-Day Moving Average | 13.12 |
| Relative Strength Index (RSI) | 5.36 |
| Average Volume (20 Days) | 158 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ryman Healthcare had revenue of 458.44 million and -55.97 million in losses. Loss per share was -0.08.
| Revenue | 458.44M |
| Gross Profit | 10.88M |
| Operating Income | -19.35M |
| Pretax Income | -59.66M |
| Net Income | -55.97M |
| EBITDA | -1.92M |
| EBIT | -19.35M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 14.37 million in cash and 1.68 billion in debt, giving a net cash position of -1.66 billion.
| Cash & Cash Equivalents | 14.37M |
| Total Debt | 1.68B |
| Net Cash | -1.66B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.74B |
| Book Value Per Share | 3.99 |
| Working Capital | -3.48B |
Cash Flow
In the last 12 months, operating cash flow was 386.84 million and capital expenditures -142.71 million, giving a free cash flow of 244.13 million.
| Operating Cash Flow | 386.84M |
| Capital Expenditures | -142.71M |
| Free Cash Flow | 244.13M |
| FCF Per Share | n/a |
Margins
Gross margin is 2.37%, with operating and profit margins of -4.22% and -12.21%.
| Gross Margin | 2.37% |
| Operating Margin | -4.22% |
| Pretax Margin | -13.01% |
| Profit Margin | -12.21% |
| EBITDA Margin | -0.42% |
| EBIT Margin | -4.22% |
| FCF Margin | 53.25% |
Dividends & Yields
Ryman Healthcare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.70% |
| Shareholder Yield | -12.70% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ryman Healthcare has an Altman Z-Score of 0.1 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.1 |
| Piotroski F-Score | 6 |